These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 10952495)

  • 61. Long-term follow-up of patients with bone metastases from differentiated thyroid carcinoma -- surgery or conventional therapy?
    Zettinig G; Fueger BJ; Passler C; Kaserer K; Pirich C; Dudczak R; Niederle B
    Clin Endocrinol (Oxf); 2002 Mar; 56(3):377-82. PubMed ID: 11940050
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Differentiated thyroid cancer: reexamination of risk groups and outcome of treatment.
    Sanders LE; Cady B
    Arch Surg; 1998 Apr; 133(4):419-25. PubMed ID: 9565123
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prognostic impact of incomplete surgical clearance of radioiodine sensitive local lymph node metastases diagnosed by post-operative (124)I-NaI-PET/CT in patients with papillary thyroid cancer.
    Sabet A; Binse I; Grafe H; Ezziddin S; Görges R; Poeppel TD; Bockisch A; Rosenbaum-Krumme SJ
    Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):1988-94. PubMed ID: 27118127
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A model for predicting outcomes in patients with differentiated thyroid cancer and model performance in comparison with other classification systems.
    Yildirim E
    J Am Coll Surg; 2005 Mar; 200(3):378-92. PubMed ID: 15737848
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution.
    Cappelli C; Pirola I; Braga M; De Martino E; Morassi ML; Gandossi E; Mattanza C; Balzano R; Castellano M; Rosei EA
    Ann Ital Chir; 2006; 77(2):107-13. PubMed ID: 17147082
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Postoperative radioactive iodine-131 ablation is not necessary among patients with intermediate-risk differentiated thyroid carcinoma: a population-based study.
    Zhang H; Cai Y; Zheng L; Zhang Z; Jiang N
    Hell J Nucl Med; 2017; 20(1):3-10. PubMed ID: 28315902
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Undetectable thyroglobulin after total thyroidectomy in patients with low- and intermediate-risk papillary thyroid cancer--is there a need for radioactive iodine therapy?
    Ibrahimpasic T; Nixon IJ; Palmer FL; Whitcher MM; Tuttle RM; Shaha A; Patel SG; Shah JP; Ganly I
    Surgery; 2012 Dec; 152(6):1096-105. PubMed ID: 23158181
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Surgical treatment of papillary and follicular thyroid carcinoma.
    Lin JD; Jeng LB; Chao TC; Weng HF; Huang HS
    Int Surg; 1996; 81(1):61-6. PubMed ID: 8803709
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Rising incidence of small size papillary thyroid cancers with no change in disease-specific survival in Finnish thyroid cancer patients.
    Hakala T; Kellokumpu-Lehtinen P; Kholová I; Holli K; Huhtala H; Sand J
    Scand J Surg; 2012; 101(4):301-6. PubMed ID: 23238509
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis.
    Sampson E; Brierley JD; Le LW; Rotstein L; Tsang RW
    Cancer; 2007 Oct; 110(7):1451-6. PubMed ID: 17705176
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Evaluation of Prognostic Factors Associated With Differentiated Thyroid Carcinoma With Pulmonary Metastasis.
    Qutbi M; Shafeie B; Amoui M; Tabeie F; Azizmohammadi Z; Mahmoud-Pashazadeh A; Javadi H; Assadi M; Asli IN
    Clin Nucl Med; 2016 Dec; 41(12):917-921. PubMed ID: 27764045
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The role of technetium-99m methoxyisobutylisonitrile scintigraphy in the planning of therapy and follow-up of patients with differentiated thyroid carcinoma after surgery.
    Rubello D; Mazzarotto R; Casara D
    Eur J Nucl Med; 2000 Apr; 27(4):431-40. PubMed ID: 10805117
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Low Recurrence Rates in a Cohort of Differentiated Thyroid Carcinoma Patients: A Referral Center Experience.
    Scheffel RS; Zanella AB; Antunes D; Dora JM; Maia AL
    Thyroid; 2015 Aug; 25(8):883-9. PubMed ID: 26061907
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Initial and Dynamic Risk Stratification of Pediatric Patients With Differentiated Thyroid Cancer.
    Sung TY; Jeon MJ; Lee YH; Lee YM; Kwon H; Yoon JH; Chung KW; Kim WG; Song DE; Hong SJ
    J Clin Endocrinol Metab; 2017 Mar; 102(3):793-800. PubMed ID: 27809646
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Outcome of management of differentiated thyroid carcinoma.
    Tarafder KH; Rahman SH; Hossain MA; Alauddin M; Islam MA; Hadi IA
    Mymensingh Med J; 2007 Jul; 16(2 Suppl):S46-52. PubMed ID: 17917631
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Drug therapy alternatives in the treatment of thyroid cancer.
    O'Doherty MJ; Coakley AJ
    Drugs; 1998 Jun; 55(6):801-12. PubMed ID: 9617595
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Correlation of clinicopathological features and expression of molecular markers with prognosis after ¹³¹I treatment of differentiated thyroid carcinoma.
    Qin C; Cau W; Zhang Y; Mghanga FP; Lan X; Gao Z; An R
    Clin Nucl Med; 2012 Mar; 37(3):e40-6. PubMed ID: 22310269
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Locally advanced differentiated thyroid carcinoma: a 35-year mono-institutional experience in 280 patients.
    Rosa Pelizzo M; Toniato A; Boschin IM; Piotto A; Bernante P; Pagetta C; Palazzi M; Maria Guolo A; Preo P; Nibale O; Rubello D
    Nucl Med Commun; 2005 Nov; 26(11):965-8. PubMed ID: 16208173
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Thyroglossal duct carcinoma in children: case presentation and review of the literature.
    Peretz A; Leiberman E; Kapelushnik J; Hershkovitz E
    Thyroid; 2004 Sep; 14(9):777-85. PubMed ID: 15361266
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Deaths due to differentiated thyroid cancer: a South Island, New Zealand experience: 1984-2009.
    Brownlie BJ; Turner J; Abdelaal AS
    N Z Med J; 2012 Oct; 125(1363):13-21. PubMed ID: 23159897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.